Form 4: Algorhythm CFO Granted Equity Options

Sentiment:

Insider Equity Grant


Algorhythm Holdings' CFO and General Counsel, Alex Andre, was granted 233,791 non-qualified stock options with an exercise price of $1.84, vesting quarterly over four years.

Summary

  • Alex Andre, the Chief Financial Officer and General Counsel of Algorhythm Holdings, Inc. (RIME), received a grant of non-qualified stock options.
  • The grant consists of 233,791 shares of the Issuer's common stock.
  • The exercise price for these options is $1.84 per share.
  • The options were granted on February 23, 2026, and will expire on February 23, 2036.
  • Vesting will occur in equal quarterly installments over a period of four years, commencing on February 23, 2026.
  • The grant was made pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value. It signals continued commitment from a key executive.

Positives

  • The grant of stock options aligns the interests of the CFO and General Counsel with those of shareholders, incentivizing long-term company performance.
  • Equity incentive plans are a standard practice for retaining and motivating key executives.

Future Outlook

The vesting schedule of the stock options, commencing on February 23, 2026, and extending over four years, indicates a long-term commitment and incentive structure for the CFO and General Counsel.

Industry Context

StockSavvy.ai notes that the granting of stock options to key executives like the CFO and General Counsel is a common practice across industries, particularly in technology and growth-oriented companies. This mechanism is widely used to align executive compensation with shareholder value creation and to foster long-term retention. Competitors often employ similar equity-based compensation strategies to attract and retain top talent.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan UtilizationThe stock option grant was made pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan, indicating the company's active use of its approved compensation framework.02/23/2026Reinforces the company's commitment to using equity-based compensation to incentivize and retain key personnel, aligning executive interests with shareholder value.

Stakeholder Impact

  • Shareholders: The grant aims to align the interests of the CFO and General Counsel with shareholders by tying a portion of their compensation to the company's stock performance.
  • Employees: May signal a stable and incentivized leadership team, potentially fostering a positive work environment.

Next Steps

  • The options will vest in equal quarterly installments over the next four years, starting February 23, 2026.

Key Dates

DateDescription
02/23/2026Date of option grant and commencement of vesting period.
02/25/2026Date the Form 4 was signed by Alex Andre.
02/23/2036Expiration date of the non-qualified stock options.

Keywords

Algorhythm Holdings, RIME, Stock Options, Equity Incentive Plan, CFO, Insider Transaction, Executive Compensation, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.